Skip to content
Guavy Logo GUAVY
Sign up
Back to Guavy Wire
Stocks

Merck Expands Singapore Lab to Boost Biosafety Testing in Asia Pacific

Guavy AI Editorial Team
Instruments
MRK
Share

Merck has expanded its Biosafety Testing Laboratory in Singapore to strengthen services across Asia Pacific. This expansion is expected to bring advanced, local contract testing services for biopharma customers in the region.

The lab will become the first BioReliance facility in Asia-Pacific to offer both Cell Line Characterization services and GMP next-generation sequencing (NGS) capabilities.

This marks a significant milestone in providing industry-leading analytical and biosafety testing services and technical expertise for the region's growing biopharma industry.

More on Stocks

Stocks just now

Boeing Unveils Ultra Low-Cost Seeker for Missile Guidance

Stocks just now

Boeing Sees Slight Uptick in Jet Deliveries Amid Industry Slump

Stocks 4m ago

Coca-Cola UNITED Expands Warehouse Operations in Alexandria

Disclaimer: Guavy is a data and market intelligence provider, not an investment advisor. The information, signals, and market analysis provided by the Guavy API and related services are for informational purposes only and are not intended as financial advice, investment recommendations, or an endorsement of any particular trading strategy. Trading in volatile markets, including cryptocurrency, carries significant risk and may not be suitable for all investors. Past performance is not indicative of future results. Users should consult with a qualified financial professional before making any investment decisions. Guavy makes no guarantee of trading profits or financial returns.

Guavy Logo GUAVY

Market sentiment intelligence for apps, funds & agents

Location

729 55 Ave SW
Calgary AB T2V 0G4
Canada

Navigate

Markets

Resources

© 2026 Guavy Inc

Terms Privacy Policy